Results 21 to 30 of about 45,189 (317)
, 2016 Rheumatoid arthritis is a chronic inflammatory joint disease, which can cause cartilage and bone damage as well as disability. Early diagnosis is key to optimal therapeutic success, particularly in patients with well-characterised risk factors for poor ...
Aletaha, Daniel +2 more
core +1 more source
Treatment of experimental amyloidosis with antirheumatic drugs
Acta Medica Lituanica, 2010 Background. Because at present there is no known specific effective therapy for secondary amyloidosis, the aim of this study was to determine whether antirheumatic drugs inhibit the development of experimental AA amyloidosis induced in C57BL/6 mice by ...
Laima LEONAVIČIENĖ +4 more
doaj +1 more source
Place of enalapril in treatment of patients with systemic lupus erythematosus and systemic sclerosis
Научно-практическая ревматология, 2003 Lupus erythematosus (SLE) and systemic sclerosis (SS). Methods. 45 SLE and 44 SS pts were included. Some of them received antirheumatic drugs in combination with enalapril other were treated with antirheumatic drugs only. The pts were examined before and
L K Kozlova, V V Bagirova
doaj +1 more source
Fluorescence optical imaging for treatment monitoring in patients with early and active rheumatoid arthritis in a 1-year follow-up period [PDF]
, 2019 BACKGROUND: Fluorescence optical imaging (FOI) enables visualization of inflammation in the hands in rheumatic joint diseases with currently a lack of long-term follow-up studies.
Backhaus, Marina +10 more
core +2 more sources
Prescription pattern in patients with rheumatoid arthritis in a teaching tertiary care hospital
MAMC Journal of Medical Sciences, 2016 Objective: This study was conducted, with the aim to analyze the pattern of use of antirheumatic drugs in a Tertiary Care Hospital in Delhi, India. Methodology: The study was carried out in 150 patients who were on treatment with antirheumatic drugs at ...
Akhil Dahiya +3 more
doaj +1 more source
Frontiers in Pharmacology, 2020 Mesenchymal stem cell (MSC)–based articular regeneration might be beneficial for both protecting and rebuilding cartilaginous tissues in the management of rheumatoid arthritis. However, it is unclear how current immunosuppressive strategies influence the
Shuang Liu +3 more
doaj +1 more source
The safety of antirheumatic drugs
Deutsches Ärzteblatt international, 2022 Drug therapy for rheumatic diseases has changed fundamentally in recent decades with the introduction of many new agents. As these drugs may have to be taken for many years, and many of them are of similar efficacy, their safety profiles play an important role in therapeutic decisionmaking.This review is based on pertinent literature retrieved by a ...
Johanna, Mucke +2 more
openaire +2 more sources
Indian Journal of Rheumatology, 2017 Rheumatoid arthritis (RA) is a chronic, disabling inflammatory arthritis often treated with a variety of disease-modifying antirheumatic drugs (DMARDs), whether conventional synthetic DMARDs (csDMARDs), targeted synthetic DMARDs (tsDMARDs), or biological
Abhishek Zanwar +6 more
doaj +1 more source
Levels of C-reactive protein associated with high and very high cardiovascular risk are prevalent in patients with rheumatoid arthritis. [PDF]
, 2009 ObjectiveC-reactive protein (CRP) levels>3 mg/L and>10 mg/L are associated with high and very high cardiovascular risk, respectively, in the general population.
Graf, Jonathan +3 more
core +4 more sources
Current issues in the management of patients with HIV infection and rheumatic diseases
Современная ревматология, 2021 According to experts, the human immunodeficiency virus (HIV) epidemic has a steady downward trend, but the attention of the medical community to this problem is not waning.
G. I. Gridneva, B. S. Belov
doaj +1 more source